Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) shares crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $2.05 and traded as low as $1.70. Arcadia Biosciences shares last traded at $2.03, with a volume of 46,524 shares trading hands.
Analysts Set New Price Targets
Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arcadia Biosciences in a research report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Arcadia Biosciences currently has a consensus rating of “Sell”.
Check Out Our Latest Research Report on RKDA
Arcadia Biosciences Trading Down 6.2%
About Arcadia Biosciences
Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.
Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.
See Also
- Five stocks we like better than Arcadia Biosciences
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- 1,500 Banks Just Handed the Fed Your Bank Account
- Trump Planning to Use Public Law 63-43: Prepare Now
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
